Literature DB >> 19186451

Parotid surgery in patients over seventy-five years old.

A Croce1, L D'Agostino, A Moretti, A Augurio.   

Abstract

Malignant parotid tumours are generally rare but become more common in the last decades of life; this increased incidence concerns mainly secondary parotid space involvement from metastasis or direct invasion. During the past five years, we observed and operated upon 84 patients for parotid diseases, performing 86 parotidectomies (2 bilateral operations). The patients included 30 (35.7%) over 75 years old (2 subjects over 90), mean age 80.5 years, object of the present study. In these 30 patients 2 chronic infections were observed, 6 benign tumours and 22 malignant tumours with only 6 primary neoplastic lesions. Overall, 14 extended radical parotidectomies were performed, 13 conservative total parotidectomies, 2 superficial parotidectomies and 1 radical parotidectomy, a few associated with neck dissection and/or radiotherapy. Three patients died in the post-operative period from heart attack. Five patients died from disease (3 from melanomas--2 after 3 years and 1 after 2 years--and 2 from primary carcinomas--1 after 2 years and 1 after 1 year). Six patients died without disease from various causes (2 after 4 years, the others after 3, 2, 1 year and 8 months). Nine patients are alive, 8 NED and 1 with disease in the ethmoid after 2 years, the latter well under control with radiotherapy. This experience implies that surgical treatment of these secondary tumours, which are performed more frequently in old age, exposes the patient to the risk of serious complications (3 patients died in the immediate post-operative period) and stresses the importance of careful evaluation of general conditions. However, surgery seems to have been the treatment indicated also in the patients who subsequently died from the disease, but in whom at least two-year survival was achieved in almost all cases. Unfortunately, because of the advanced age of the patients, the final results are penalized by deaths from natural causes. It is, nevertheless, encouraging that over one third of the patients operated upon are free of disease.

Entities:  

Mesh:

Year:  2008        PMID: 19186451      PMCID: PMC2689531     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  15 in total

1.  Metastatic disease to the parotid gland.

Authors:  Michel Nuyens; Jonas Schüpbach; Edouard Stauffer; Peter Zbären
Journal:  Otolaryngol Head Neck Surg       Date:  2006-12       Impact factor: 3.497

2.  [Lymphatic metastases in the parotid region from malignant skin neoplasm of the head: considerations for surgical treatment based on personal clinical experience].

Authors:  A Tullio; B Bianchi; E Sesenna
Journal:  Acta Otorhinolaryngol Ital       Date:  2001-02       Impact factor: 2.124

3.  Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.

Authors:  Brian A Moore; Randal S Weber; Victor Prieto; Adel El-Naggar; F Christopher Holsinger; Xian Zhou; J Jack Lee; Scott Lippman; Gary L Clayman
Journal:  Laryngoscope       Date:  2005-09       Impact factor: 3.325

4.  Parotidectomy in the treatment of aggressive cutaneous malignancies.

Authors:  Stephen Y Lai; Gregory S Weinstein; Ara A Chalian; David I Rosenthal; Randal S Weber
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-05

5.  Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland.

Authors:  Christopher J O'Brien; Edward B McNeil; Jeremy D McMahon; Irvin Pathak; Christopher S Lauer; Michael A Jackson
Journal:  Head Neck       Date:  2002-05       Impact factor: 3.147

6.  Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland.

Authors:  C J O'Brien; E B McNeil; J D McMahon; I Pathak; C S Lauer
Journal:  Head Neck       Date:  2001-09       Impact factor: 3.147

7.  Extended parotidectomy.

Authors:  M De Vincentiis; G Magliulo; P Soldo; V Manciocco; G Pagliuca; R Del Gaizo; A Gallo
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

8.  Major salivary gland diseases. Multicentre study.

Authors:  R Fiorella; V Di Nicola; M L Fiorella; D A Spinelli; F Coppola; P Luperto; L Madami
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

9.  Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases.

Authors:  Luc P Bron; Sean J Traynor; Edward B McNeil; Christopher J O'Brien
Journal:  Laryngoscope       Date:  2003-06       Impact factor: 3.325

Review 10.  Salivary gland tumours.

Authors:  P M Speight; A W Barrett
Journal:  Oral Dis       Date:  2002-09       Impact factor: 3.511

View more
  2 in total

1.  Analysis of prognostic risk factors and treatment of parotid cancer.

Authors:  Jinbiao Shang; Yingjie Wu; Wendong Wang; Kejing Wang; Minghua Ge
Journal:  Oncol Lett       Date:  2012-04-02       Impact factor: 2.967

2.  Histopathological changes in parotid gland following submandibular gland failure: an experimental animal study.

Authors:  Yavuz Sultan Selim Yıldırım; Irfan Kaygusuz; Ibrahim Hanifi Ozercan; Hasan Cetiner; Oner Sakallioglu; Abdulvahap Akyigit; Sertac Duzer
Journal:  Braz J Otorhinolaryngol       Date:  2018-04-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.